PEPTIDE BUNDLE

Weight Management Research Stack

Tirzepatide + NAD+ for comprehensive metabolic research

R$149R$169

SAVE 12% — R$20 OFF

1 PRODUCTSFREE UK DELIVERY>99% PURITY

BUNDLE CONTENTS

What's Included

POPULAR

Tirzepatide

Dual Incretin Research Peptide

R$16920 mg · 3 mL

PURITY: >99%FILL VOLUME: 3 mLDOSAGE: 10 mg

STACK BENEFITS

Why This Stack Works

Investigated for dual GIP/GLP-1 receptor-mediated appetite and glucose regulation

Studied for mitochondrial fat oxidation and energy production pathways

Research focus on AMPK and sirtuin activation for metabolic homeostasis

Investigated for insulin sensitivity improvement via complementary mechanisms

Studied for lipid metabolism and adipose tissue remodelling

Hormonal + cellular energy approach to metabolic research

RESEARCH PROTOCOL

Protocol Overview

The Weight Management protocol pairs Tirzepatide's incretin-mediated metabolic effects with NAD+'s cellular energy support. Tirzepatide is administered via the ORYN pen with standard dose escalation (matching published clinical trial protocols). NAD+ provides daily metabolic support, enhancing mitochondrial function and activating AMPK/sirtuin pathways that promote fat oxidation. This combination addresses both the central (appetite/glucose) and peripheral (cellular metabolism) aspects of metabolic research.

PRODUCTS

DURATION

30 Days

PURITY

>99%

SAVINGS

12%

About This Bundle

The Weight Management Research Stack combines Tirzepatide's dual GIP/GLP-1 receptor agonism with NAD+'s metabolic and mitochondrial support for the most comprehensive metabolic research protocol available. Tirzepatide targets appetite regulation, glucose metabolism, and lipid handling through incretin pathways, while NAD+ supports cellular energy production, fat oxidation, and AMPK/sirtuin activation. This dual-mechanism approach addresses both the hormonal and cellular energy aspects of metabolic research.

Weight Management Research Stack— Frequently Asked Questions

Why combine Tirzepatide with NAD+ for metabolic research?

Tirzepatide acts centrally through GIP/GLP-1 receptors to regulate appetite, insulin secretion, and glucose metabolism. NAD+ acts peripherally to support mitochondrial function, fat oxidation, and cellular energy production. Together, they address both the hormonal and bioenergetic aspects of metabolism, providing a more comprehensive research protocol than either alone.

How does the Tirzepatide dose escalation work?

Published clinical trials use a step-wise dose escalation: starting at 2.5mg weekly for 4 weeks, then increasing to 5mg, 7.5mg, 10mg, and potentially 15mg at 4-week intervals based on the research protocol. ORYN Tirzepatide pens are calibrated for these standard research doses.

Can the MediT Pen be used instead of the standard Tirzepatide Pen?

Yes. The MediT Pen contains the same tirzepatide compound in an alternative pen format. Both are suitable for this research stack. Choose based on your preferred dosing mechanism and protocol requirements.

MORE STACKS